化学原料药
(C060201.国证.三级)A股通融
(
市盈率
52.67
市净率
2.569
股息率
1.03%
【静1.05%】
)·市值加权
发布时间2011-01-04样本数47市值3,343.42亿元A股市值3,314.72亿元流通市值2,842.28亿元自由流通市值1,908.49亿元陆股通持仓金额占市值比例1.15% (37.63亿元2025-12-31) 融资融券余额占市值比例3.53% (融资余额113.22亿元融券余额3,810.96万元2026-06-30) 行业估值数据计算说明文档行业财务数据计算说明文档
二级:制药 (C0602)
(
市盈率
35.46
市净率
2.527
股息率
1.62%
【静1.64%】
)·市值加权
一级:医药卫生 (C06)
(
市盈率
45.84
市净率
2.749
股息率
1.38%
【静1.45%】
)·市值加权
关注
284
发表讨论

化学原料药(C060201).国证 - 样本列表

最后更新于：2026-07-01

# 公司名称 省份关注时间市值市盈率市净率股息率涨跌幅今年以来投资收益率公司性质财报日期公告时间营业总收入归属于母公司普通股股东的净利润归属于母公司普通股股东的加权ROE
累计同比累计同比累计同比
1新翰宇药业通
300199.sz		--211.36亿元223.6228.5020%8.38%33.69%自然人2026-Q12026-04-292.99亿元-3.49%1.28亿元82.94%18.86%7.47%
关注
309
2皓元医药通
688131.sh		--203.64亿元83.036.4860.24%0.95%32.49%自然人2026-Q12026-04-307.29亿元20.21%0.68亿元8.75%2.14%0%
关注
190
3普洛药业通
000739.sz		--199.14亿元22.353.1643.35%3.18%7.01%集体2026-Q12026-04-2124.47亿元-10.36%2.49亿元0.19%3.86%-0.14%
关注
981
4川宁生物通
301301.sz		--184.16亿元31.132.3562.09%3.90%-17.18%自然人2026-Q12026-04-2310.94亿元-15.61%1.11亿元-61.58%1.36%-2.22%
关注
135
5博瑞医药通
688166.sh		--143.59亿元282.405.8320.05%-5.88%-32.81%自然人2026-Q12026-04-303.25亿元30.52%0.09亿元-28.29%0.37%-0.16%
关注
250
6富祥股份通
300497.sz		--125.72亿元3,198.065.5960%5.32%54.47%自然人2026-Q12026-04-283.58亿元53.09%0.61亿元26.33倍2.76%2.66%
关注
4726
7九洲药业通
603456.sh		--123.10亿元18.881.3982.15%1.32%-22.06%自然人2026-Q12026-04-2412.01亿元-19.43%1.72亿元-31.22%1.95%-0.94%
关注
659
8花园生物通
300401.sz		--121.84亿元47.113.7810.50%2.38%49.50%自然人2026-Q12026-04-182.77亿元-15.17%0.50亿元-47.91%1.43%-1.52%
关注
567
9国邦医药通
605507.sh		--120.40亿元15.711.4372.78%3.99%-10.66%自然人2026-Q12026-04-1615.21亿元5.61%1.61亿元-25.28%1.86%-0.78%
关注
109
10宏源药业通
301246.sz		--115.76亿元45.482.5230.17%7.58%15.97%自然人2026-Q12026-04-297.04亿元62.31%1.44亿元15.24倍3.19%2.98%
关注
48
11浙江医药通
600216.sh		--113.38亿元15.091.0092.37%3.42%-14.94%自然人2026-Q12026-04-2421.91亿元-2.86%2.87亿元-29.84%2.59%-1.18%
关注
577
12东诚药业通
002675.sz		--105.38亿元51.572.4970.63%1.83%-6.42%自然人2026-Q12026-04-286.26亿元-8.82%0.33亿元35.19%0.77%0.22%
关注
441
13新华制药通
000756.sz		--102.55亿元39.191.9171.02%3.88%-4.48%国有2026-Q12026-04-2924.23亿元-0.28%0.84亿元-25.15%1.59%-0.62%
关注
340
14ST诺泰通
688076.sh		--88.18亿元28.512.9341.25%3.72%-25.05%自然人2026-Q12026-04-305.53亿元-2.23%1.29亿元-15.17%4.24%-1.33%
关注
170
15海翔药业通
002099.sz		--87.90亿元-119.011.7790%2.84%-12.98%自然人2026-Q12026-04-294.86亿元0.01%0.26亿元186.53%0.53%0.35%
关注
324
16美诺华通
603538.sh		--86.95亿元77.523.7640.42%10.02%86.12%自然人2026-Q12026-04-253.38亿元22.12%0.31亿元46.84%1.32%0.36%
关注
341
17奥锐特通
605116.sh		--80.26亿元20.393.1321.71%4.44%-19.76%自然人2026-Q12026-04-243.89亿元-3.17%0.64亿元-46.47%2.38%-2.59%
关注
212
18天宇股份通
300702.sz		--73.95亿元77.252.0180.24%5.41%-9.72%自然人2026-Q12026-04-248.12亿元6.89%0.42亿元-51.04%1.15%-1.28%
关注
428
19昊帆生物通
301393.sz		--72.48亿元63.973.0710.60%3.61%32.95%自然人2026-Q12026-04-241.72亿元27.16%0.33亿元-3.89%1.41%-0.11%
关注
62
20尔康制药通
300267.sz		--71.78亿元-18.181.7850%5.45%2.05%自然人2026-Q12026-04-242.47亿元-30.03%0.13亿元-53.37%0.33%-0.30%
关注
267
21奥翔药业通
603229.sh		--67.59亿元62.562.8550.79%5.17%-17.94%自然人2026-Q12026-04-293.09亿元0.66%0.97亿元-18.91%4.60%-0.51%
关注
241
22新圣诺生物通
688117.sh		--63.63亿元35.925.9230.87%6.84%8.04%自然人2026-Q12026-04-242.44亿元32.52%0.66亿元40.84%6.08%1.08%
关注
113
23科源制药通
301281.sz		--60.96亿元258.934.3950.09%14.18%92.31%自然人2026-Q12026-04-241.61亿元45.05%0.30亿元30.27%2.19%0.51%
关注
35
24津药药业通
600488.sh		--55.69亿元210.891.8261.02%5.59%24.69%2026-Q12026-04-256.08亿元-22.61%0.14亿元-76.07%0.46%-1.42%
关注
156
25兄弟科技通
002562.sz		--50.86亿元46.481.4262.25%2.30%-29.75%自然人2026-Q12026-04-279.87亿元7.40%0.35亿元68.47%0.95%0.28%
关注
318
26键凯科技通
688356.sh		--49.63亿元68.713.7590.38%6.16%-0.02%自然人2026-Q12026-04-290.79亿元14.53%0.22亿元88.67%1.69%0.76%
关注
200
27亨迪药业通
301211.sz		--48.90亿元144.672.1660.51%3.45%-3.57%自然人2026-Q12026-04-231.20亿元5.00%0.09亿元-10.73%0.40%-0.05%
关注
73
28司太立通
603520.sh		--47.61亿元282.771.9312.76%-1.63%18.50%自然人2026-Q12026-04-307.11亿元3.70%0.21亿元46.08%0.82%0.28%
关注
418
29森萱医药通
920946.bj		--43.20亿元28.903.4681.58%3.69%-2.42%2026-Q12026-04-291.60亿元27.67%0.47亿元62.05%3.65%1.24%
关注
67
30向日葵通
300111.sz		--38.10亿元-402.395.6290%2.78%-51.71%自然人2026-Q12026-04-270.55亿元-24.46%-0.05亿元-38.83倍-0.77%-0.75%
关注
147
31新天地通
301277.sz		--36.46亿元36.182.4172.15%6.29%-19.74%自然人2026-Q12026-04-242.07亿元-5.84%0.36亿元-36.19%2.30%-1.30%
关注
65
32共同药业通
300966.sz		--32.64亿元-45.814.4520.16%2.91%43.78%自然人2026-Q12026-04-291.62亿元16.32%0.03亿元195.59%0.39%0.27%
关注
81
33永安药业通
002365.sz		--31.30亿元90.461.5910.92%4.94%-28.17%自然人2026-Q12026-04-302.36亿元37.83%0.08亿元277.16%0.39%0.61%
关注
247
34海森药业通
001367.sz		--28.78亿元21.551.9080.61%2.50%-13.53%自然人2026-Q12026-04-281.07亿元-9.53%0.29亿元-7.38%1.91%-0.38%
关注
66
35拓新药业通
301089.sz		--28.66亿元-37.421.9430%10.92%-19.11%自然人2026-Q12026-04-280.93亿元-4.63%-0.11亿元-194.82%-0.71%-0.48%
关注
101
36山河药辅通
300452.sz		--28.37亿元16.082.9712.46%3.60%-7.31%自然人2026-Q12026-04-232.61亿元5.45%0.47亿元-0.25%4.56%-0.52%
关注
446
37同和药业通
300636.sz		--28.09亿元39.521.1870.60%5.02%-10.40%自然人2026-Q12026-04-291.84亿元-1.34%0.19亿元-9.63%0.79%-0.11%
关注
174
38赛托生物通
300583.sz		--22.23亿元-52.911.2590.13%4.36%-14.39%自然人2026-Q12026-04-283.28亿元26.24%0.04亿元113.15%0.21%1.72%
关注
100
39富士莱通
301258.sz		--21.89亿元58.241.1880.89%4.87%-25.92%自然人2026-Q12026-04-230.93亿元-17.88%-0.03亿元-111.56%-0.15%-1.41%
关注
86
40东亚药业通
605177.sh		--20.45亿元-18.481.2310%4.21%0.17%自然人2026-Q12026-04-302.65亿元38.58%-0.35亿元-408.73%-1.97%-1.60%
关注
102
41广济药业通
000952.sz		--19.73亿元-4.933.1640%4.98%-19.06%国有2026-Q12026-04-251.63亿元9.84%-0.32亿元12.75%-4.96%-1.50%
关注
209
42中哲精化通
000953.sz		--19.59亿元320.2312.6890%3.68%-25.90%自然人2026-Q12026-04-280.37亿元-8.83%95.36万元-29.98%0.62%-0.31%
关注
121
43新赣江通
920367.bj		--17.16亿元138.633.5600.12%8.03%20.30%自然人2026-Q12026-04-290.36亿元4.61%0.03亿元-41.61%0.64%-0.48%
关注
26
44无锡晶海通
920547.bj		--14.21亿元22.311.9881.09%4.10%-21.89%自然人2026-Q12026-04-271.10亿元5.47%0.20亿元3.36%2.75%-0.10%
关注
26
45海昇药业通
920656.bj		--14.07亿元18.442.0582.84%3.61%-17.16%自然人2026-Q12026-04-160.66亿元56.36%0.20亿元51.52%2.82%0.81%
关注
36
46峆一药业通
920478.bj		--11.52亿元33.712.2691.03%15.98%-20.42%自然人2026-Q12026-04-280.46亿元-42.54%0.03亿元-83.25%0.62%-3.27%
关注
27
47欧康医药通
920230.bj		--10.58亿元87.982.6011.42%7.12%-11.46%自然人2026-Q12026-04-290.56亿元-4.88%0.02亿元31.81%0.53%0.12%
关注
25

©2016-2024 理杏仁 | 北京乾谦慧科技有限公司 | 违法和不良信息举报中心 互联网违法和不良信息投诉：010-86460785

推荐Chrome浏览器 | 京公网安备11010502033936号 | 京B2-20201471 | 京ICP备16057978号 | 用户协议

风险提示: 本站所有免费及收费信息和数据仅供参考，不构成投资建议，理杏仁不承担由此导致的任何法律责任。